PHARMAQ Analytiq offers histopathology, the microscopic examination of disease-related changes in thin tissue sections. The method is considered to be a cornerstone of fish diagnostics. These days, histopathology is often combined with RT-PCR and microbiology in order to ascertain the cause and impact of diseases in the fish.
Health challenges in the aquaculture industry can often be multifactorial. By examining the tissue response of the fish – in combination with detection of possible infectious agents – we can better understand the aetiology of the condition under investigation.
This method can be used to detect both infectious and non-infectious diseases. Additionally, we can assess the degree and duration of potential tissue damage. For some diseases, such as heart- and muscle inflammation (HSMI) and cardiomyopathy syndrome (CMS), histopathology is the most useful method for assessment of extent of tissue damage and diagnosis. Histopathology is also pivotal for detecting emerging diseases.
By combining Real-Time qPCR, microbiology and histopathology, PHARMAQ Analytiq can not only assess the impact of the disease, but also increase the likelihood of establishing the cause.
Histopathological assessment of heart and gill tissue, in advance of treatments, can be a very useful tool in determining how well a stock is likely to tolerate the intervention, so informing the manager as to whether to go ahead or delay the operation.
PHARMAQ Analytiq has a world-leading team of veterinary pathologists globally. Our team has a broad experience and expertise in fish pathology.
In our state-of-the-art histopathology lab, as well as performing routine histology we also have expertise in specialist staining techniques , as well as immunohistochemistry.
PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com. Privacy Policy. Cookie Policy. Terms of Use.
Copyright © 2020 Zoetis LLC. All rights reserved.